Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
01 1Centrient Pharmaceuticals
02 6Dr. Reddy's Laboratories
03 5TAPI Technology & API Services
04 1ALP Pharm
05 1Amoli Organics
06 1Apotex Pharmachem
07 2Arch Pharmalabs
08 1Asymchem Laboratories
09 1Aurobindo Pharma Limited
10 3Biocon
11 2Cadila Pharmaceuticals
12 1Changzhou Pharmaceutical Factory
13 1Chromo Laboratories
14 1EPHAR BIOLOGICAL AND CHEMICAL CO LTD
15 1HEC Pharm
16 2Hetero Drugs
17 1Ind Swift Laboratories Limited
18 1Jiangsu Alpha Pharmaceutical Co., Ltd.
19 1Jubilant Generics
20 1Laurus Labs
21 1Lek Pharmaceuticals
22 3Lupin Ltd
23 3MSN Laboratories
24 2Macleods Pharmaceuticals Limited
25 2Mankind Pharma
26 3Morepen Laboratories
27 1Par Pharmaceutical
28 1Pfizer Inc
29 3RANBAXY LABORATORIES LIMITED
30 1Raks Pharma
31 1Signa S.A. de C.V.
32 1Sun Pharmaceutical Industries Limited
33 1Torrent Pharmaceuticals Limited
34 1Viatris
35 1Vijayasri Organics Limited
36 1Zhejiang Haisen Pharmaceutical Co., Ltd.
37 1Zhejiang Hisun Pharmaceutical
38 1Zhejiang Jiangbei Pharmaceutical
39 3Zhejiang Neo-Dankong Pharm. Co.,Ltd.
40 4Zydus Lifesciences
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
GDUFA
DMF Review : Complete
Rev. Date : 2016-05-31
Pay. Date : 2015-08-20
DMF Number : 29520
Submission : 2015-08-03
Status :
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-27
Pay. Date : 2013-02-05
DMF Number : 18468
Submission : 2005-06-29
Status :
Type : II
TAPI offers customized CDMO Solutions for API development and manufacturing services.
GDUFA
DMF Review : Complete
Rev. Date : 2013-07-08
Pay. Date : 2012-11-07
DMF Number : 26571
Submission : 2012-11-29
Status :
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2020-02-20
Pay. Date : 2020-01-28
DMF Number : 34423
Submission : 2019-12-31
Status :
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25902
Submission : 2012-03-23
Status :
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-07
Pay. Date : 2013-09-25
DMF Number : 23664
Submission : 2010-03-30
Status :
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-27
Pay. Date : 2013-02-06
DMF Number : 21125
Submission : 2007-12-14
Status :
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-27
Pay. Date : 2013-01-04
DMF Number : 19997
Submission : 2006-11-27
Status :
Type : II
TAPI offers customized CDMO Solutions for API development and manufacturing services.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20069
Submission : 2006-12-20
Status :
Type : II
TAPI offers customized CDMO Solutions for API development and manufacturing services.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19880
Submission : 2006-10-17
Status :
Type : II
We have 40 companies offering atorvastatin calcium anhydrous
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
